Published in Eur J Biochem on November 03, 1986
Interleukin 1 potentiates the lethal effect of tumor necrosis factor alpha/cachectin in mice. J Exp Med (1988) 2.92
Local production of tumor necrosis factor alpha, interleukin 1, and interleukin 6 in meningococcal meningitis. Relation to the inflammatory response. J Exp Med (1989) 2.68
Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38. Mol Cell Biol (2002) 2.10
Interleukin 1 suppresses expression of cartilage-specific types II and IX collagens and increases types I and III collagens in human chondrocytes. J Clin Invest (1988) 1.89
N-terminal methionine-specific peptidase in Salmonella typhimurium. Proc Natl Acad Sci U S A (1987) 1.66
Role of TNF and IL-1 in infections with Toxoplasma gondii. Immunology (1990) 1.61
The human prointerleukin 1 beta gene requires DNA sequences both proximal and distal to the transcription start site for tissue-specific induction. Mol Cell Biol (1993) 1.45
Crystal structure of the cytokine interleukin-1 beta. EMBO J (1988) 1.33
Plasminogen activator inhibitor 2: regulation of gene transcription during phorbol ester-mediated differentiation of U-937 human histiocytic lymphoma cells. Mol Cell Biol (1987) 1.32
Endothelial cell activation induced by tumor necrosis factor and lymphotoxin. Am J Pathol (1989) 1.23
Infusions of recombinant human interleukins 1 alpha and 1 beta cause hypercalcemia in normal mice. Proc Natl Acad Sci U S A (1988) 1.20
Phenotypic analysis of murine long-term hemopoietic reconstituting cells quantitated competitively in vivo and comparison with more advanced colony-forming progeny. J Exp Med (1995) 1.20
Determination of solvent content in cavities in IL-1beta using experimentally phased electron density. Proc Natl Acad Sci U S A (2006) 1.11
Interleukin 1 as an autocrine growth factor for acute myeloid leukemia cells. Proc Natl Acad Sci U S A (1989) 1.11
Activation of protein breakdown and prostaglandin E2 production in rat skeletal muscle in fever is signaled by a macrophage product distinct from interleukin 1 or other known monokines. J Clin Invest (1988) 1.10
Induction of the E-selectin promoter by interleukin 1 and tumour necrosis factor alpha, and inhibition by glucocorticoids. Biochem J (1997) 1.04
IL-1 enhances expansion, effector function, tissue localization, and memory response of antigen-specific CD8 T cells. J Exp Med (2013) 1.03
Interferon gamma drastically modifies the regulation of interleukin 1 genes by endotoxin in U937 cells. J Clin Invest (1990) 1.00
C-terminal peptide identification by fast atom bombardment mass spectrometry. Biochem J (1988) 0.99
Synergistic effects of recombinant tumour necrosis factor and interferon-gamma on rat thyroid cell growth and Ia antigen expression. Immunology (1988) 0.95
Antidiabetic effects of interleukin 1. Proc Natl Acad Sci U S A (1989) 0.90
Synthesis of a Cys949Tyr alpha 2-macroglobulin thiol ester mutant: co-transfection with wild-type alpha 2-macroglobulin in an episomal expression system. Biochem J (1995) 0.81
Analysis of mutations in the putative nuclear localization sequence of interleukin-1 beta. Biochem J (1991) 0.80
Secretion of recombinant proteins via the chaperone/usher pathway in Escherichia coli. Appl Environ Microbiol (2001) 0.80
Characterization of recombinant-derived granulocyte-colony stimulating factor (G-CSF). Biochem J (1988) 0.76
Purification and characterization of 5-ketofructose reductase from Erwinia citreus. Biochem J (1988) 0.75
Preparation of Soluble Proteins from Escherichia coli. Curr Protoc Protein Sci (2014) 0.75
Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J Exp Med (1985) 8.16
Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial. JAMA (1999) 7.37
Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature (1993) 6.67
Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem (1992) 5.60
Production of collagenase and prostaglandins by isolated adherent rheumatoid synovial cells. Proc Natl Acad Sci U S A (1976) 5.40
Generation of high curvature membranes mediated by direct endophilin bilayer interactions. J Cell Biol (2001) 5.37
Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte-activating factor (interleukin 1). Proc Natl Acad Sci U S A (1981) 4.89
Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. N Engl J Med (1988) 4.69
Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum (1990) 4.39
Isolation and structure of a human fibroblast interferon gene. Nature (1980) 4.16
Domains of the integrase protein of human immunodeficiency virus type 1 responsible for polynucleotidyl transfer and zinc binding. Proc Natl Acad Sci U S A (1993) 3.99
CCR5 is characteristic of Th1 lymphocytes. Nature (1998) 3.92
The relationship of bone and blood lead to hypertension. The Normative Aging Study. JAMA (1996) 3.87
Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis. Arthritis Rheum (1995) 3.83
Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am J Pathol (1993) 3.73
Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J Virol (1993) 3.68
Evidence for tumour necrosis factor/cachectin production in cancer. Lancet (1987) 3.66
Structural analysis of the sequence coding for an inducible 26-kDa protein in human fibroblasts. Eur J Biochem (1986) 3.63
Molecular cloning of human interleukin 2 cDNA and its expression in E. coli. Nucleic Acids Res (1983) 3.44
Human recombinant interleukin 1 stimulates collagenase and prostaglandin E2 production by human synovial cells. J Clin Invest (1986) 3.43
Structure of the AAA ATPase p97. Mol Cell (2000) 3.37
Participation of monocyte-macrophages and lymphocytes in the production of a factor that stimulates collagenase and prostaglandin release by rheumatoid synovial cells. J Clin Invest (1979) 3.34
Human ADP-ribosylation factor-activated phosphatidylcholine-specific phospholipase D defines a new and highly conserved gene family. J Biol Chem (1995) 3.10
Molecular cloning of mouse tumour necrosis factor cDNA and its eukaryotic expression. Nucleic Acids Res (1985) 3.09
Isolation of two new members of the NF-AT gene family and functional characterization of the NF-AT proteins. Immunity (1995) 3.07
Limitations of he Dixon plot for ascertaining naure of enzyme inhibition. Tex Rep Biol Med (1969) 2.91
Fitness to drive and the older patient: awareness among hospital physicians. Lancet (1994) 2.91
Collagenase production by rheumatoid synovial cells: stimulation by a human lymphocyte factor. Science (1977) 2.91
Concomitant secretion of prourokinase and of a plasminogen activator-specific inhibitor by cultured human monocytes-macrophages. J Exp Med (1984) 2.78
Leflunomide: mode of action in the treatment of rheumatoid arthritis. Ann Rheum Dis (2000) 2.59
Fastrach--a new intubating laryngeal mask airway: successful use in patients with difficult airways. Can J Anaesth (1998) 2.49
Prostaglandin production by rheumatoid synovial cells: stimulation by a factor from human mononuclear Cells. J Exp Med (1977) 2.47
National study of microphthalmia, anophthalmia, and coloboma (MAC) in Scotland: investigation of genetic aetiology. J Med Genet (2002) 2.39
Resistance to fever induction and impaired acute-phase response in interleukin-1 beta-deficient mice. Immunity (1995) 2.39
Conditional survival among patients with carcinoma of the lung. Chest (1999) 2.30
Purification of a factor from human blood monocyte-macrophages which stimulates the production of collagenase and prostaglandin E2 by cells cultured from rheumatoid synovial tissues. FEBS Lett (1981) 2.27
TLR-4, IL-1R and TNF-R signaling to NF-kappaB: variations on a common theme. Cell Mol Life Sci (2008) 2.23
Binding of human tumor necrosis factor to high affinity receptors on HeLa and lymphoblastoid cells sensitive to growth inhibition. J Biol Chem (1985) 2.18
A urine inhibitor of interleukin 1 activity that blocks ligand binding. J Immunol (1987) 2.17
Design and application of a cytokine-receptor-based interaction trap. Nat Cell Biol (2001) 2.17
Recent developments in the pathophysiology and management of pre-eclampsia. Br J Anaesth (1996) 2.14
Standards for reporting interventions in controlled trials of acupuncture: the STRICTA recommendations. Complement Ther Med (2001) 2.13
Characterization of five genes in the upper-pathway operon of TOL plasmid pWW0 from Pseudomonas putida and identification of the gene products. J Bacteriol (1989) 2.13
Tumor necrosis factor causes bronchial hyperresponsiveness in rats. Am Rev Respir Dis (1992) 2.11
Contribution of interleukin 17 to synovium matrix destruction in rheumatoid arthritis. Cytokine (2000) 2.11
Redesigning metabolic routes: manipulation of TOL plasmid pathway for catabolism of alkylbenzoates. Science (1987) 2.07
Purification and biologic characterization of a specific tumor necrosis factor alpha inhibitor. J Biol Chem (1989) 2.07
Airway dysfunction in nasal polyposis: a spectrum of asthmatic disease? Clin Exp Allergy (2011) 2.06
High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. Am Rev Respir Dis (1992) 2.05
Contributions of community involvement to organizational-level empowerment: the federal Healthy Start experience. Health Educ Behav (2001) 2.03
Prescribing limitations. Br Dent J (2001) 2.03
Specific complex of human immunodeficiency virus type 1 rev and nucleolar B23 proteins: dissociation by the Rev response element. Mol Cell Biol (1991) 2.02
Interleukin 5 synthesis by eosinophils: association with granules and immunoglobulin-dependent secretion. J Exp Med (1994) 2.01
Induction of the synthesis of tumor necrosis factor receptors by interferon-gamma. J Immunol (1986) 2.00
Delay in thrombolytic treatment in acute myocardial infarction: the role of the accident and emergency department. Arch Emerg Med (1990) 2.00
Relation between tumor necrosis factor-alpha and granulocyte elastase-alpha 1-proteinase inhibitor complexes in the plasma of patients with cystic fibrosis. Am Rev Respir Dis (1989) 1.99
Molecular cloning and expression of human tumor necrosis factor and comparison with mouse tumor necrosis factor. Eur J Biochem (1985) 1.99
[Effectivity of an occlusion-supporting PC-based visual training programme by horizontal drifting sinus gratings in children with amblyopia]. Klin Monbl Augenheilkd (2012) 1.98
Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol (1998) 1.97
Human immunodeficiency virus rev protein recognizes a target sequence in rev-responsive element RNA within the context of RNA secondary structure. J Virol (1990) 1.94
Anisotropic rotational diffusion of perdeuterated HIV protease from 15N NMR relaxation measurements at two magnetic fields. J Biomol NMR (1996) 1.94
Characterization of factors that direct transcription of rat ribosomal DNA. Mol Cell Biol (1990) 1.93
Comparative immunogenicity of hepatitis B virus core and E antigens. J Immunol (1988) 1.92
Human TNF mutants with selective activity on the p55 receptor. Nature (1993) 1.91
Dilemmas of "informed consent" in children. N Engl J Med (1973) 1.87
Sphygmomanometers: errors due to blocked vents. Br Med J (1979) 1.86
A human inhibitor of tumor necrosis factor alpha. J Exp Med (1988) 1.85
Temperature-dependent expression of flagella of Listeria monocytogenes studied by electron microscopy, SDS-PAGE and western blotting. J Gen Microbiol (1988) 1.85
Design of access control methods for protecting the confidentiality of patient information in networked systems. Proc AMIA Annu Fall Symp (1997) 1.84
Behavioral features in semantic dementia vs other forms of progressive aphasias. Neurology (2006) 1.80
Increased prostaglandin production by human monocytes after membrane receptor activation. J Immunol (1979) 1.77
Monoclonal antibodies reactive with hairy cell leukemia. Blood (1989) 1.75
Fyn and Lyn phosphorylate the Fc receptor gamma chain downstream of glycoprotein VI in murine platelets, and Lyn regulates a novel feedback pathway. Blood (2000) 1.75
Increased apoptotic peripheral blood neutrophils in systemic lupus erythematosus: relations with disease activity, antibodies to double stranded DNA, and neutropenia. Ann Rheum Dis (1999) 1.75
Sedation for oocyte retrieval using target controlled infusion of propofol and incremental alfentanil delivered by non-anaesthetists. Anaesthesia (2010) 1.74
I-TRAF is a novel TRAF-interacting protein that regulates TRAF-mediated signal transduction. Proc Natl Acad Sci U S A (1996) 1.74
Sequence determination of the Sendai virus fusion protein gene. J Gen Virol (1985) 1.73
Cloning and structure of the human immune interferon-gamma chromosomal gene. EMBO J (1982) 1.71
Properties of the nuclear P1 protein, a mammalian homologue of the yeast Mcm3 replication protein. Nucleic Acids Res (1992) 1.71
Synthesis of interleukin 1/endogenous pyrogen in the brain of endotoxin-treated mice: a step in fever induction? J Immunol (1984) 1.71
Tyrosine phosphorylation of the Fc receptor gamma-chain in collagen-stimulated platelets. J Biol Chem (1996) 1.71
Prostaglandin E2 and collagenase production by fibroblasts and synovial cells is regulated by urine-derived human interleukin 1 and inhibitor(s). J Clin Invest (1986) 1.70
Interleukin 1 is present in normal human epidermis. J Immunol (1986) 1.70
Allergen immunotherapy: therapeutic vaccines for allergic diseases. World Health Organization. American academy of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol (1998) 1.70
Botulinum toxin (Dysport) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging study. J Neurol Neurosurg Psychiatry (2000) 1.70
A randomized, controlled trial of routine early abdominal computed tomography in patients presenting with non-specific acute abdominal pain. Clin Radiol (2007) 1.70
IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. J Clin Invest (1995) 1.69
Evidence for a unique human fibroblast interferon (IFN-beta 1) chromosomal gene, devoid of intervening sequences. Nucleic Acids Res (1981) 1.67
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Induction of human interleukin 1 mRNA measured by collagenase- and prostaglandin E2-stimulating activity in rheumatoid synovial cells. Eur J Immunol (1984) 1.66
Recommendations for control and prevention of human immunodeficiency virus (HIV) infection in intravenous drug users. Ann Intern Med (1989) 1.65
GPs' experiences of primary care mental health research: a qualitative study of the barriers to recruitment. Fam Pract (2007) 1.64
Postnatal development of the cutaneous flexor reflex: comparative study of preterm infants and newborn rat pups. Dev Med Child Neurol (1988) 1.64
Requirements for interleukin-4-induced gene expression and functional characterization of Stat6. Mol Cell Biol (1996) 1.64
Oligomerization of glycolipid-anchored and soluble forms of the vesicular stomatitis virus glycoprotein. J Virol (1989) 1.64